3D bioprinted, vascularized neuroblastoma tumor environment in fluidic chip devices for precision medicine drug testing

D Nothdurfter, C Ploner, DC Coraça-Huber… - …, 2022 - iopscience.iop.org
Neuroblastoma is an extracranial solid tumor which develops in early childhood and still has
a poor prognosis. One strategy to increase cure rates is the identification of patient-specific …
被引用次数：42 相关文章
[PDF] researchgate.net

[PDF][PDF] 3D bioprinted, vascularized neuroblastoma tumor environment in fluidic chip devices for precision medicine drug testing

D Nothdurfter, C Ploner, DC Coraça-Huber… - researchgate.net
Neuroblastoma is an extracranial solid tumor which develops in early childhood and still has
a poor prognosis. One strategy to increase cure rates is the identification of patient-specific …

3D bioprinted, vascularized neuroblastoma tumor environment in fluidic chip devices for precision medicine drug testing

D Nothdurfter, C Ploner, DC Coraça-Huber… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Neuroblastoma is an extracranial solid tumor which develops in early childhood and still has
a poor prognosis. One strategy to increase cure rates is the identification of patient-specific …

3D bioprinted, vascularized neuroblastoma tumor environment in fluidic chip devices for precision medicine drug testing.

D Nothdurfter, C Ploner, DC Coraça-Huber… - Biofabrication, 2022 - europepmc.org
Neuroblastoma is an extracranial solid tumor which develops in early childhood and still has
a poor prognosis. One strategy to increase cure rates is the identification of patient-specific …

3D bioprinted, vascularized neuroblastoma tumor environment in fluidic chip devices for precision medicine drug testing

D Nothdurfter, C Ploner, DC Coraça-Huber… - …, 2022 - ui.adsabs.harvard.edu
Neuroblastoma is an extracranial solid tumor which develops in early childhood and still has
a poor prognosis. One strategy to increase cure rates is the identification of patient-specific …